National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Pediatrics. 2019 Jan;143(1). doi: 10.1542/peds.2018-2130.
: media-1vid110.1542/5839998266001PEDS-VA_2018-2130 BACKGROUND: Freshman college students living in residence halls have previously been identified as being at an increased risk for meningococcal disease. In this evaluation, we assess the incidence and characteristics of meningococcal disease in college-aged young adults in the United States.
The incidence and relative risk (RR) of meningococcal disease among college students compared with noncollege students aged 18 to 24 years during 2014-2016 were calculated by using data from the National Notifiable Diseases Surveillance System and enhanced meningococcal disease surveillance. Differences in demographic characteristics and clinical features of meningococcal disease cases were assessed. Available meningococcal isolates were characterized by using slide agglutination, polymerase chain reaction, and whole genome sequencing.
From 2014 to 2016, 166 cases of meningococcal disease occurred in persons aged 18 to 24 years, with an average annual incidence of 0.17 cases per 100 000 population. Six serogroup B outbreaks were identified on college campuses, accounting for 31.7% of serogroup B cases in college students during this period. The RR of serogroup B meningococcal (MenB) disease in college students versus noncollege students was 3.54 (95% confidence interval: 2.21-5.41), and the RR of serogroups C, W, and Y combined was 0.56 (95% confidence interval: 0.27-1.14). The most common serogroup B clonal complexes identified were CC32/ET-5 and CC41/44 lineage 3.
Although the incidence is low, among 18- to 24-year-olds, college students are at an increased risk for sporadic and outbreak-associated MenB disease. Providers, college students, and parents should be aware of the availability of MenB vaccines.
媒体-1vid110.1542/5839998266001PEDS-VA_2018-2130 背景:先前已经确定居住在宿舍的大一新生患脑膜炎球菌病的风险增加。在这项评估中,我们评估了美国大学年龄的年轻人中脑膜炎球菌病的发病率和特征。
利用国家法定传染病监测系统和强化脑膜炎球菌病监测的数据,计算了 2014-2016 年期间,18 至 24 岁的大学生与非大学生相比脑膜炎球菌病的发病率和相对风险(RR)。评估了脑膜炎球菌病病例的人口统计学特征和临床特征的差异。通过玻片凝集、聚合酶链反应和全基因组测序对可用的脑膜炎球菌分离株进行了特征描述。
2014 年至 2016 年期间,18 至 24 岁人群中有 166 例脑膜炎球菌病发生,平均每年发病率为每 100000 人口 0.17 例。在大学校园内发现了 6 起 B 群脑膜炎球菌爆发,占该期间大学生 B 群脑膜炎球菌(MenB)病例的 31.7%。大学生 MenB 疾病的 RR 与非大学生相比为 3.54(95%置信区间:2.21-5.41),C、W 和 Y 群的 RR 为 0.56(95%置信区间:0.27-1.14)。鉴定出的最常见 B 群克隆复合体是 CC32/ET-5 和 CC41/44 谱系 3。
尽管发病率较低,但在 18-24 岁人群中,大学生患散发性和爆发性相关 MenB 疾病的风险增加。提供者、大学生和家长应该了解 MenB 疫苗的可用性。